|
1-(meta-chlorophenyl)piperazine (mCPP) is a 5HT releaser that possesses mixed 5HT2A/2C receptor agonist/antagonist actions. It shares several pharmacological properties with MDMA (ecstasy).
In laboratory administration studies, individuals with prior experience of the drug ecstasy reported that mCPP in doses from 17.5 to 52.5 mg/70kg body weight produced MDMA (ecstasy)-like stimulant and hallucinogenic effects. However, unlike MDMA, no increase in blood pressure and heart rate were recorded. Other studies have confirmed these findings in other groups of ecstasy user and cocaine dependent individuals.
Piperazines can interact with anti depressant medication. If you have a history of mental health issues, heart disorders or high blood pressure problems or are currently on any other medication please do not purchase these products
|
